Cargando…
Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact
SIMPLE SUMMARY: Although much progress has been made in recent years in the clinical management of solid tumors, pancreatic ductal adenocarcinoma (PDAC) remains a malignancy with limited therapeutical options. Indeed, responses to standard chemotherapy and targeted therapies vary widely when adminis...
Autores principales: | Gutiérrez, María Laura, Muñoz-Bellvís, Luis, Orfao, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430663/ https://www.ncbi.nlm.nih.gov/pubmed/34503261 http://dx.doi.org/10.3390/cancers13174451 |
Ejemplares similares
-
Detection of circulating tumor cells in blood of pancreatic ductal adenocarcinoma patients
por: Mayado, Andrea, et al.
Publicado: (2020) -
Association between Genetic Subgroups of Pancreatic Ductal Adenocarcinoma Defined by High Density 500 K SNP-Arrays and Tumor Histopathology
por: Gutiérrez, María Laura, et al.
Publicado: (2011) -
Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas
por: Gutiérrez, María Laura, et al.
Publicado: (2015) -
Cancer-Associated Fibroblasts’ Functional Heterogeneity in Pancreatic Ductal Adenocarcinoma
por: Awaji, Mohammad, et al.
Publicado: (2019) -
The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma
por: Evan, Theodore, et al.
Publicado: (2022)